Infectious Diseases
Data demonstrate therapeutic benefit of expanded myeloid progenitors
Published in Blood Weekly, March 31st, 2005
In preclinical studies, Cellerant's MP cell product resulted in a survival benefit in immune-compromised mice exposed to lethal fungal infections.
"These experiments lay the foundation for Cellerant's myeloid progenitor product program: a cell product that can be manufactured and given to patients like a drug, without the kind of immunologic matching that currently limits cell therapy," stated Timothy Fong, VP of Research at Cellerant.
"Cellerant is pleased to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-03-31)
More Articles from Blood Weekly
- Blood Banking
Quality control programs ensures quantity/quality of preserved cord blood - Embryonic Stem Cell Research
Frozen-thawed embryos superior to fresh for embryonic stem cell establishment - Tissue Engineering
Surgisis collagen mesh useful alternative for tissue replacement in pediatrics - Tissue Engineering
Synchronous contractions induced in cardiac tissue engineered constructs - Umbilical Cord Blood
Cord blood banking regulated in the EU to assure safety/efficacy - Acute Myeloid Leukemia
SU11248 produces short-term partial remissions in leukemia patients - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
